Ads
related to: Fasenra- Eosinophil Diseases
Learn About A Treatment For
Multiple Eosinophil-Driven Diseases
- Adverse Reaction Info
Explore Safety Information For
A Severe Asthma Treatment.
- Prescribing Information
Get Prescribing Information For A
Severe Eosinophilic Asthma Therapy.
- Clinical Trial Data
View Clinical Trial Data For A
Severe Eosinophilic Asthma Med.
- Eosinophil Diseases
Search results
AstraZeneca (AZN) Q1 Earnings & Sales Beat Estimates, Stock Up
Zacks via Yahoo Finance· 1 day agoIn R&I, Symbicort sales rose 14% in the quarter to $769 million, driven by strong underlying demand...
Health Care Roundup: Market Talk
The Wall Street Journal· 2 days agoThe Anglo-Swedish pharmaceutical giant’s current full-year targets are 4% below consensus, but an upgrade is likely for later this year, the analysts...
Astrazeneca (AZN) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks· 2 days agoWhile the top- and bottom-line numbers for Astrazeneca (AZN) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 4 days agoAstraZeneca’s other drugs, Fasenra, Calquence and newer products, asthma drug Tezspire and lupus...
AstraZeneca Posts Bumper Earnings On Strong Sales From Cancer Drugs, Sticks To Annual Guidance
Benzinga via Yahoo Finance· 2 days agoThursday, AstraZeneca Plc (NASDAQ:AZN) reported first-quarter sales of $12.68 billion, up 17% year...
11 Best Low Price Pharma Stocks To Invest In
Insider Monkey via Yahoo Finance· 6 days agoIn this piece, we will take a look at the 13 best low price pharma stocks to invest in. If you want to skip our overview of the pharma industry and want...
Insights Into Astrazeneca (AZN) Q1: Wall Street Projections for Key Metrics
Zacks via Yahoo Finance· 5 days agoBeyond analysts' top -and-bottom-line estimates for Astrazeneca (AZN), evaluate projections for some...
Deutsche Bank Aktiengesellschaft Reiterates “Hold” Rating for AstraZeneca (LON:AZN)
ETF DAILY NEWS· 2 days agoAstraZeneca (LON:AZN – Get Free Report)‘s stock had its “hold” rating reaffirmed by research analysts at Deutsche Bank Aktiengesellschaft in a research report issued on Tuesday, MarketBeat.com ...
Greenleaf Trust Sells 1,500 Shares of AstraZeneca PLC (NASDAQ:AZN)
ETF DAILY NEWS· 6 days agoGreenleaf Trust trimmed its position in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 5.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities ...
Cetera Trust Company N.A Purchases Shares of 3,700 AstraZeneca PLC (NASDAQ:AZN)
ETF DAILY NEWS· 5 days agoCetera Trust Company N.A purchased a new position in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with ...
Ads
related to: Fasenra